Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancerAnnika Jögi, Karin Jirström|Modern Pathology|2009Cited by 85
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancerAnnika Jögi, Sara Alkner|PLoS ONE|2019Cited by 72
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cellsMuhammad Wasi Alam, Annika Jögi|Oncotarget|2016Cited by 22